No abstract available
MeSH terms
-
Biosimilar Pharmaceuticals*
-
Clinical Trials, Phase I as Topic
-
Drug Approval
-
Female
-
Filgrastim / pharmacology*
-
Filgrastim / therapeutic use*
-
Hematologic Agents / pharmacology*
-
Hematologic Agents / therapeutic use*
-
Humans
-
Randomized Controlled Trials as Topic
-
United States
-
United States Food and Drug Administration
Substances
-
Biosimilar Pharmaceuticals
-
Hematologic Agents
-
Filgrastim